These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Somatomedin C in pediatric pathophysiology. Cacciari E; Cicognani A Pediatrician; 1987; 14(3):146-53. PubMed ID: 3453495 [TBL] [Abstract][Full Text] [Related]
5. [Somatomedins and their significance in pediatrics]. Vetter U; Teller WM Klin Padiatr; 1985; 197(5):378-85. PubMed ID: 3906254 [TBL] [Abstract][Full Text] [Related]
6. [Insulin-like growth factors in human pathology]. Minuto F; Barreca A Recenti Prog Med; 1992 May; 83(5):262-74. PubMed ID: 1439105 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122 [TBL] [Abstract][Full Text] [Related]
8. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Wiesli P; Zwimpfer C; Zapf J; Schmid C Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly. Wass JA J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991 [TBL] [Abstract][Full Text] [Related]
10. Somatomedin C/insulin-like growth factor I levels after treatment of acromegaly. Kao PC; Laws ER; Zimmerman D Ann Clin Lab Sci; 1992; 22(2):95-9. PubMed ID: 1562170 [TBL] [Abstract][Full Text] [Related]
11. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656 [TBL] [Abstract][Full Text] [Related]
15. Hormonal diagnosis of GH hypersecretory states. Grottoli S; Gasco V; Ragazzoni F; Ghigo E J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657 [TBL] [Abstract][Full Text] [Related]
16. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related]
17. Value of insulin-like growth factor system markers in the assessment of growth hormone status. Clemmons DR Endocrinol Metab Clin North Am; 2007 Mar; 36(1):109-29. PubMed ID: 17336738 [TBL] [Abstract][Full Text] [Related]
18. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444 [TBL] [Abstract][Full Text] [Related]
19. [Somatomedins (author's transl)]. Binoux M Sem Hop; 1981 May 8-15; 57(17-18):923-8. PubMed ID: 6165086 [TBL] [Abstract][Full Text] [Related]
20. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients. Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]